litlas
ログインアカウント作成

Janet Schnee

1987–2023 年に発表

25
論文数
18,006
被引用数
24
h 指数
25
i10 指数

被引用数

Janet Schnee の年別被引用数1989 年: 被引用 2 件1991 年: 被引用 2 件1992 年: 被引用 1 件2000 年: 被引用 4 件2001 年: 被引用 8 件2002 年: 被引用 8 件2003 年: 被引用 7 件2004 年: 被引用 11 件2005 年: 被引用 10 件2006 年: 被引用 9 件2007 年: 被引用 9 件2008 年: 被引用 27 件2009 年: 被引用 42 件2010 年: 被引用 94 件2011 年: 被引用 75 件2012 年: 被引用 80 件2013 年: 被引用 96 件2014 年: 被引用 61 件2015 年: 被引用 53 件2016 年: 被引用 57 件2017 年: 被引用 48 件2018 年: 被引用 28 件2019 年: 被引用 116 件2020 年: 被引用 231 件2021 年: 被引用 691 件2022 年: 被引用 1,059 件2023 年: 被引用 786 件2024 年: 被引用 1,147 件2025 年: 被引用 577 件2026 年: 被引用 10 件1990 年は被引用が無いため表示していません1993〜1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,649 件、この内訳の 18.3%イギリス: 引用元論文 763 件、この内訳の 8.5%ドイツ: 引用元論文 608 件、この内訳の 6.7%カナダ: 引用元論文 537 件、この内訳の 6%イタリア: 引用元論文 501 件、この内訳の 5.6%中国: 引用元論文 406 件、この内訳の 4.5%オランダ: 引用元論文 370 件、この内訳の 4.1%フランス: 引用元論文 320 件、この内訳の 3.5%日本: 引用元論文 288 件、この内訳の 3.2%スウェーデン: 引用元論文 258 件、この内訳の 2.9%オーストラリア: 引用元論文 237 件、この内訳の 2.6%スペイン: 引用元論文 228 件、この内訳の 2.5%
0%18.3%その他 31.6%

機関

分野

  • Medicine93.8%
  • Biochemistry, Genetics and Molecular Biology3.9%
  • Immunology and Microbiology0.8%
  • Economics, Econometrics and Finance0.2%
  • Neuroscience0.2%
  • Pharmacology, Toxicology and Pharmaceutics0.2%
  • その他0.9%

トピック

  • Diabetes Treatment and Management15.2%
  • Heart Failure Treatment and Management10.5%
  • Cardiovascular Function and Risk Factors9.5%
  • Atrial Fibrillation Management and Outcomes4.8%
  • Venous Thromboembolism Diagnosis and Management4.6%
  • Pancreatic function and diabetes3.9%
  • その他51.5%

共著者

全論文

検索で開く
  1. Empagliflozin in Heart Failure with a Preserved Ejection Fraction

    著者: Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Edimar Alcides Bocchi, Michael Böhm, Hans‐Peter Brunner‐La Rocca, Dong‐Ju Choi, Vijay Chopra, Eduardo Chuquiure‐Valenzuela, Nadia Giannetti, Juan Esteban Gómez‐Mesa, Stefan Janssens, James L. Januzzi, José Ramón González‐Juanatey, Béla Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Michele Senni, David Sim, Jindřich Špinar, Iain Squire, Stefano Taddei, Hiroyuki Tsutsui, Subodh Verma, Dragoş Vinereanu, Jian Zhang, Peter E. Carson, Carolyn S.P. Lam, Nikolaus Marx, Cordula Zeller, Naveed Sattar, Waheed Jamal, Sven Schnaidt, Janet Schnee, Martina Brueckmann, Stuart Pocock, Faı̈ez Zannad, Milton Packer - New England Journal of Medicine 2021 被引用: 4,618

  2. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

    著者: Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart Pocock, Peter E. Carson, James L. Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Alcides Bocchi, Michael Böhm, Dong‐Ju Choi, Vijay Chopra, Eduardo Chuquiure‐Valenzuela, Nadia Giannetti, Stefan Janssens, Jian Zhang, José Ramón González‐Juanatey, Sanjay Kaul, Hans‐Peter Brunner‐La Rocca, Béla Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie‐France Seronde, Jindřich Špinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faı̈ez Zannad - New England Journal of Medicine 2020 被引用: 5,037

  3. Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial

    著者: Milton Packer, Javed Butler, Faı̈ez Zannad, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Peter E. Carson, Inder S. Anand, Wolfram Doehner, Markus Haass, Michel Komajda, Alan B. Miller, Steen Pehrson, John R. Teerlink, Sven Schnaidt, Cordula Zeller, Janet Schnee, Stefan D. Anker, for the EMPEROR-Preserved Trial Study Group - Circulation 2021 被引用: 343

  4. Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function

    著者: Faı̈ez Zannad, João Pedro Ferreira, Stuart Pocock, Cordula Zeller, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Sibylle J. Hauske, Martina Brueckmann, Egon Pfarr, Janet Schnee, Christoph Wanner, Milton Packer - Circulation 2020 被引用: 278

  5. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction

    著者: Javed Butler, Milton Packer, Gerasimos Filippatos, João Pedro Ferreira, Cordula Zeller, Janet Schnee, Martina Brueckmann, Stuart Pocock, Faı̈ez Zannad, Stefan D. Anker - European Heart Journal 2021 被引用: 253

  6. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

    著者: Sam Schulman, Clive Kearon, Ajay K. Kakkar, Patrick Mismetti, Sebastian Schellong, Henry Eriksson, David Baanstra, Janet Schnee, Samuel Z. Goldhaber - New England Journal of Medicine 2009 被引用: 2,571

  7. Angiotensin II, adhesion, and cardiac fibrosis

    著者: Janet Schnee - Cardiovascular Research 2000 被引用: 253

  8. Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial

    著者: James L. Januzzi, Faı̈ez Zannad, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart Pocock, João Pedro Ferreira, Naveed Sattar, Subodh Verma, Ola Vedin, Janet Schnee, Tomoko Iwata, Dan Cotton, Milton Packer - Journal of the American College of Cardiology 2021 被引用: 101

  9. Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR-Preserved Trial

    著者: Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Muhammad Shahzeb Khan, João Pedro Ferreira, Edimar Alcides Bocchi, Michael Böhm, Hans‐Peter Brunner‐La Rocca, Dong‐Ju Choi, Vijay Chopra, Eduardo Chuquiure‐Valenzuela, Nadia Giannetti, Juan Esteban Gómez‐Mesa, Stefan Janssens, James L. Januzzi, José Ramón González‐Juanatey, Béla Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Michele Senni, Marie‐France Seronde, David Sim, Jindřich Špinar, Iain Squire, Stefano Taddei, Hiroyuki Tsutsui, Subodh Verma, Dragoş Vinereanu, Jian Zhang, Waheed Jamal, Sven Schnaidt, Janet Schnee, Martina Brueckmann, Stuart Pocock, Faı̈ez Zannad, Milton Packer - European Journal of Heart Failure 2020 被引用: 136

  10. Evaluation of the Effects of Sodium–Glucose Co-Transporter 2 Inhibition with Empagliflozin on Morbidity and Mortality in Patients with Chronic Heart Failure and a Preserved Ejection Fraction: Rationale for and Design of the EMPEROR-Preserved Trial

    著者: Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Waheed Jamal, Afshin Salsali, Janet Schnee, Karen Kimura, Cordula Zeller, Jyothis T. George, Martina Brueckmann, Faı̈ez Zannad, Milton Packer - European Journal of Heart Failure 2019 被引用: 251

  11. Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

    著者: Carolyn S.P. Lam, João Pedro Ferreira, Egon Pfarr, David Sim, Hiroyuki Tsutsui, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, Stuart Pocock, Naveed Sattar, Subodh Verma, Martina Brueckmann, Janet Schnee, Daniel Cotton, Faı̈ez Zannad, Milton Packer - European Heart Journal 2021 被引用: 57

  12. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

    著者: Bengt I. Eriksson, O.E. Dahl, Nadia Rosencher, Andreas Kurth, C. Niek van Dijk, Simon P. Frostick, Peter Kälebo, Anita Vedel Christiansen, Stefan Hantel, Rohan Hettiarachchi, Janet Schnee, Harry R. Büller - Journal of Thrombosis and Haemostasis 2007 被引用: 984

  13. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)

    著者: Ola Dahl, Michael H. Huo, Andreas Kurth, Stefan Hantel, Karin Hermansson, Janet Schnee, Richard J. Friedman, Bengt I. Eriksson, for the RE-NOVATE II Study Group - Thrombosis and Haemostasis 2011 被引用: 399

  14. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

    著者: Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher, Andreas Kurth, C. Niek van Dijk, Simon P. Frostick, Martin H. Prins, Rohan Hettiarachchi, Stefan Hantel, Janet Schnee, Harry R. Büller - The Lancet 2007 被引用: 1,116

  15. Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

    著者: Jeffrey S Ginsberg, Jeffrey S. Ginsberg, Bruce L. Davidson, Philip C. Comp, Charles W. Francis, Richard J. Friedman, Michael H. Huo, Jay R. Lieberman, James E. Muntz, Gary E. Raskob, M L Clements, Stefan Hantel, Janet Schnee - The Journal of Arthroplasty 2008 被引用: 631

  16. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    著者: Stefan D. Anker, Javed Butler, Muhammad Usman, Gerasimos Filippatos, João Pedro Ferreira, Edimar Alcides Bocchi, Michael Böhm, Hans‐Peter Brunner‐La Rocca, Dong‐Ju Choi, Vijay Chopra, Eduardo Chuquiure‐Valenzuela, Nadia Giannetti, Juan Esteban Gómez‐Mesa, Stefan Janssens, James L. Januzzi, José Ramón González‐Juanatey, Béla Merkely, Stephen J. Nicholls, Sergio V. Perrone, Ileana L. Piña, Piotr Ponikowski, Michele Senni, David Sim, Jindřich Špinar, Iain Squire, Stefano Taddei, Hiroyuki Tsutsui, Subodh Verma, Dragoş Vinereanu, Jian Zhang, Tomoko Iwata, Janet Schnee, Martina Brueckmann, Stuart Pocock, Faı̈ez Zannad - Nature Medicine 2022 被引用: 37

  17. Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial

    著者: Peter E. Carson, John R. Teerlink, Michel Komajda, Inder S. Anand, Stefan D. Anker, Javed Butler, Wolfram Doehner, João Pedro Ferreira, Gerasimos Filippatos, Markus Haass, Alan B. Miller, Steen Pehrson, Stuart Pocock, Sven Schnaidt, Janet Schnee, Faı̈ez Zannad, Milton Packer - JACC Heart Failure 2023 被引用: 16

  18. Osteopontin modulates angiotensin II- induced fibrosis in the intact murine heart

    著者: Alan R. Collins, Janet Schnee, Wei Wang, Sarah Kim, Michael C. Fishbein, Dennis Bruemmer, Ronald E. Law, Susanne B. Nicholas, Robert S. Ross, Willa A. Hsueh - Journal of the American College of Cardiology 2004 被引用: 142

  19. Human homologs of the Xenopus oocyte cortical granule lectin XL35

    著者: J K Lee, Janet Schnee, Mabel Pang, Margreet A. Wolfert, Linda G. Baum, Kelley W. Moremen, Marsha L. Pierce - Glycobiology 2001 被引用: 110

  20. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: A pooled analysis of three trials

    著者: Richard J. Friedman, O.E. Dahl, Nadia Rosencher, Joseph A. Caprini, Andreas Kurth, C. W. Francis, Andreas Clemens, Stefan Hantel, Janet Schnee, Bengt I. Eriksson - Thrombosis Research 2010 被引用: 141

  21. Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

    著者: Milton Packer, Stefan D. Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart Pocock, Hans‐Peter Brunner‐La Rocca, Stefan Janssens, Hiroyuki Tsutsui, Jian Zhang, Martina Brueckmann, Waheed Jamal, Daniel Cotton, Tomoko Iwata, Janet Schnee, Faı̈ez Zannad - European Heart Journal 2020 被引用: 136

  22. A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system

    著者: Janet Schnee, Kathy Fraeman, Kimberly Siu, Matthew W. Reynolds, Jenna Collins, Eric Schwartzman, Todd C. Villines - Thrombosis and Haemostasis 2015 被引用: 125

  23. A Randomized Trial of Dabigatran Versus Warfarin in the Treatment of Acute Venous Thromboembolism (RE-COVER II)

    著者: Sam Schulman, Ajay K. Kakkar, Sebastian Schellong, Samuel Z. Goldhaber, Eriksson Henry, Patrick Mismetti, Anita Vedel Christiansen, Janet Schnee, Clive Kearon - Blood 2011 被引用: 93

  24. Construction and expression of a recombinant antibody-targeted plasminogen activator.

    著者: Janet Schnee, Marschall S. Runge, Gary R. Matsueda, N. W. Hudson, Jonathan G. Seidman, E Haber, Thomas Quertermous - National Academy of Sciences, Proceedings of the National Academy of Sciences 1987 被引用: 91